This year’s prestigious Lasker medical awards recognize a trio of scientists without whom Ozempic and other blockbuster ...

Three scientists were recognized by the Lasker Awards for their work on the GLP-1 hormone. Others were honored for work to ...

As GLP-1 weight loss drugs fly off shelves, Kourtney Kardashian Barker is getting in on the hustle — well, sort of. As ...

Among patients receiving persistent medication at one year, 61% of patients prescribed semaglutide for obesity achieved at ...

Mazdutide is a dual glucagon-like peptide-1 receptor (GLP-1R)/glucagon receptor (GCGR) agonist. Targeting glucagon receptor ...

Medicare may cover Wegovy for adults with cardiovascular disease and either obesity or overweight. Learn more about Medicare ...

The overall findings from the landmark FLOW trial confirmed the potential of glucagon-like peptide 1 (GLP-1) receptor ...

The study concentrates on the FDA-approved injectable medications semaglutide and liraglutide. A study conducted by the ...

Three scientists are honoured for developing a class of blockbuster weight-loss drugs. Is a Nobel prize on the way?

The demand for weight loss medications are on the rise, and now, “natural” GLP-1s are being marketed to help you lose weight.

A systematic review reveals that GLP-1 receptor agonists may help reduce certain substance use disorders, but findings are ...

Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window Glucagon-like peptide 1 (GLP-1) receptor agonists like semaglutide (Ozempic, ...